Silicon Valley Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Silicon Valley Capital Partners's BMY Position: Q1 2026 in Review
Silicon Valley Capital Partners increased its Bristol-Myers Squibb (BMY) stake by 5.3% in Q1 2026, buying an estimated $3.38K and bringing the position to 1,154 shares worth $70K. The position accounts for 0.01% of the portfolio, ranked #129.
Silicon Valley Capital Partners first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Silicon Valley Capital Partners held 1,154 shares of Bristol-Myers Squibb worth $70K as of Q1 2026.
- Silicon Valley Capital Partners bought 58 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.38K.
- Bristol-Myers Squibb made up 0.01% of Silicon Valley Capital Partners's portfolio in Q1 2026, its #129 holding.
- Silicon Valley Capital Partners first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Silicon Valley Capital Partners's 13F filing for Q1 2026, filed 19 May 2026.